

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.72227544 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.72227544 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 7.19811241 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.19811241 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.43253703 |
| 6 | fatty acid elongation (GO:0030497) | 6.25262237 |
| 7 | bile acid biosynthetic process (GO:0006699) | 5.64677990 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.43936877 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.29323796 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.29323796 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.29323796 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.09338643 |
| 13 | alpha-linolenic acid metabolic process (GO:0036109) | 5.03377968 |
| 14 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.98654832 |
| 15 | tryptophan metabolic process (GO:0006568) | 4.92654489 |
| 16 | protein K11-linked deubiquitination (GO:0035871) | 4.88667521 |
| 17 | complement activation, alternative pathway (GO:0006957) | 4.87311339 |
| 18 | regulation of protein activation cascade (GO:2000257) | 4.82839600 |
| 19 | central nervous system myelination (GO:0022010) | 4.81188639 |
| 20 | axon ensheathment in central nervous system (GO:0032291) | 4.81188639 |
| 21 | cysteine metabolic process (GO:0006534) | 4.77988539 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 4.67714484 |
| 23 | bile acid metabolic process (GO:0008206) | 4.67622039 |
| 24 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.65482673 |
| 25 | protein carboxylation (GO:0018214) | 4.65482673 |
| 26 | regulation of complement activation (GO:0030449) | 4.59054517 |
| 27 | regulation of fibrinolysis (GO:0051917) | 4.58322362 |
| 28 | aromatic amino acid family metabolic process (GO:0009072) | 4.57769534 |
| 29 | coenzyme catabolic process (GO:0009109) | 4.50693591 |
| 30 | high-density lipoprotein particle remodeling (GO:0034375) | 4.44700687 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 4.44229368 |
| 32 | very long-chain fatty acid metabolic process (GO:0000038) | 4.40750279 |
| 33 | urea cycle (GO:0000050) | 4.39800423 |
| 34 | urea metabolic process (GO:0019627) | 4.39800423 |
| 35 | tyrosine metabolic process (GO:0006570) | 4.39799573 |
| 36 | heme transport (GO:0015886) | 4.29746788 |
| 37 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.21731923 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.18307369 |
| 39 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 4.17712987 |
| 40 | cholesterol biosynthetic process (GO:0006695) | 4.15893526 |
| 41 | ethanol oxidation (GO:0006069) | 4.15414738 |
| 42 | nitrogen cycle metabolic process (GO:0071941) | 4.15410844 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 4.13835090 |
| 44 | regulation of hippo signaling (GO:0035330) | 4.11020881 |
| 45 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 4.08772065 |
| 46 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 4.06502727 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.04871535 |
| 48 | serine family amino acid catabolic process (GO:0009071) | 3.98642644 |
| 49 | cellular ketone body metabolic process (GO:0046950) | 3.94418017 |
| 50 | signal peptide processing (GO:0006465) | 3.93449877 |
| 51 | serine family amino acid biosynthetic process (GO:0009070) | 3.92250377 |
| 52 | aldehyde catabolic process (GO:0046185) | 3.91968037 |
| 53 | cellular biogenic amine catabolic process (GO:0042402) | 3.91240323 |
| 54 | amine catabolic process (GO:0009310) | 3.91240323 |
| 55 | acetyl-CoA metabolic process (GO:0006084) | 3.88896914 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 3.88746029 |
| 57 | cofactor catabolic process (GO:0051187) | 3.87373028 |
| 58 | acylglycerol homeostasis (GO:0055090) | 3.85321259 |
| 59 | triglyceride homeostasis (GO:0070328) | 3.85321259 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 3.84774318 |
| 61 | bile acid and bile salt transport (GO:0015721) | 3.81841400 |
| 62 | indole-containing compound metabolic process (GO:0042430) | 3.81011538 |
| 63 | serine family amino acid metabolic process (GO:0009069) | 3.80682799 |
| 64 | glutamate metabolic process (GO:0006536) | 3.80150087 |
| 65 | homocysteine metabolic process (GO:0050667) | 3.79661021 |
| 66 | indolalkylamine metabolic process (GO:0006586) | 3.78130373 |
| 67 | neural tube formation (GO:0001841) | 3.78083565 |
| 68 | reverse cholesterol transport (GO:0043691) | 3.77628324 |
| 69 | cellular glucuronidation (GO:0052695) | 3.77572091 |
| 70 | cellular amino acid catabolic process (GO:0009063) | 3.76614468 |
| 71 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.76273344 |
| 72 | reflex (GO:0060004) | 3.75385424 |
| 73 | plasma lipoprotein particle remodeling (GO:0034369) | 3.74357178 |
| 74 | protein-lipid complex remodeling (GO:0034368) | 3.74357178 |
| 75 | macromolecular complex remodeling (GO:0034367) | 3.74357178 |
| 76 | L-serine metabolic process (GO:0006563) | 3.72733157 |
| 77 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.72669800 |
| 78 | opsonization (GO:0008228) | 3.71272162 |
| 79 | negative regulation of sterol transport (GO:0032372) | 3.66503697 |
| 80 | negative regulation of cholesterol transport (GO:0032375) | 3.66503697 |
| 81 | cholesterol efflux (GO:0033344) | 3.66423002 |
| 82 | amino-acid betaine metabolic process (GO:0006577) | 3.65835488 |
| 83 | fibrinolysis (GO:0042730) | 3.64758804 |
| 84 | sterol biosynthetic process (GO:0016126) | 3.62445565 |
| 85 | short-chain fatty acid metabolic process (GO:0046459) | 3.62244674 |
| 86 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.61006732 |
| 87 | thioester biosynthetic process (GO:0035384) | 3.60636114 |
| 88 | acyl-CoA biosynthetic process (GO:0071616) | 3.60636114 |
| 89 | imidazole-containing compound metabolic process (GO:0052803) | 3.58294961 |
| 90 | thioester metabolic process (GO:0035383) | 3.58269169 |
| 91 | acyl-CoA metabolic process (GO:0006637) | 3.58269169 |
| 92 | phospholipid efflux (GO:0033700) | 3.56755941 |
| 93 | glycine metabolic process (GO:0006544) | 3.56706987 |
| 94 | behavioral response to nicotine (GO:0035095) | 3.56602521 |
| 95 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.56536217 |
| 96 | cytolysis (GO:0019835) | 3.55618287 |
| 97 | protein K48-linked deubiquitination (GO:0071108) | 3.54660574 |
| 98 | negative regulation of lipase activity (GO:0060192) | 3.50609930 |
| 99 | regulation of sarcomere organization (GO:0060297) | 3.50210726 |
| 100 | benzene-containing compound metabolic process (GO:0042537) | 3.50197717 |
| 101 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.48559419 |
| 102 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.48559419 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.47247146 |
| 104 | glucuronate metabolic process (GO:0019585) | 3.47247146 |
| 105 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.46831814 |
| 106 | lysine metabolic process (GO:0006553) | 3.45846694 |
| 107 | lysine catabolic process (GO:0006554) | 3.45846694 |
| 108 | ketone body metabolic process (GO:1902224) | 3.44508323 |
| 109 | cellular modified amino acid catabolic process (GO:0042219) | 3.44327363 |
| 110 | aspartate family amino acid catabolic process (GO:0009068) | 3.43811560 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.43390197 |
| 112 | ethanol metabolic process (GO:0006067) | 3.42838138 |
| 113 | regulation of gene silencing by miRNA (GO:0060964) | 3.42391544 |
| 114 | regulation of gene silencing by RNA (GO:0060966) | 3.42391544 |
| 115 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.42391544 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.41113830 |
| 117 | cholesterol homeostasis (GO:0042632) | 3.40142853 |
| 118 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.35307264 |
| 119 | detection of light stimulus involved in visual perception (GO:0050908) | 3.35307264 |
| 120 | regulation of establishment of cell polarity (GO:2000114) | 3.34828961 |
| 121 | flavonoid metabolic process (GO:0009812) | 3.33443187 |
| 122 | serotonin metabolic process (GO:0042428) | 3.31772374 |
| 123 | phospholipid translocation (GO:0045332) | 3.31373882 |
| 124 | lipid translocation (GO:0034204) | 3.31373882 |
| 125 | righting reflex (GO:0060013) | 3.27947697 |
| 126 | establishment of protein localization to Golgi (GO:0072600) | 3.26251829 |
| 127 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.22712748 |
| 128 | central nervous system neuron axonogenesis (GO:0021955) | 3.22338603 |
| 129 | photoreceptor cell maintenance (GO:0045494) | 3.21304862 |
| 130 | oxidative demethylation (GO:0070989) | 3.17649303 |
| 131 | thyroid hormone metabolic process (GO:0042403) | 3.17352542 |
| 132 | primary amino compound metabolic process (GO:1901160) | 3.17265686 |
| 133 | drug catabolic process (GO:0042737) | 3.15585055 |
| 134 | NAD biosynthetic process (GO:0009435) | 3.14789051 |
| 135 | positive regulation of developmental pigmentation (GO:0048087) | 3.14177169 |
| 136 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.12561179 |
| 137 | regulation of pigment cell differentiation (GO:0050932) | 3.12362513 |
| 138 | protein K63-linked deubiquitination (GO:0070536) | 3.09276136 |
| 139 | sulfation (GO:0051923) | 3.07282737 |
| 140 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.06201684 |
| 141 | behavioral response to ethanol (GO:0048149) | 2.99284980 |
| 142 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.98463280 |
| 143 | neuronal action potential propagation (GO:0019227) | 2.94960719 |
| 144 | exogenous drug catabolic process (GO:0042738) | 2.93544918 |
| 145 | startle response (GO:0001964) | 2.90384729 |
| 146 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.90126861 |
| 147 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.86952172 |
| 148 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.86119691 |
| 149 | cellular response to sterol (GO:0036315) | 2.85138379 |
| 150 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.83643133 |
| 151 | negative regulation of mast cell activation (GO:0033004) | 2.77439662 |
| 152 | nucleobase catabolic process (GO:0046113) | 2.76293052 |
| 153 | auditory receptor cell stereocilium organization (GO:0060088) | 2.75489639 |
| 154 | snRNA transcription (GO:0009301) | 2.73120969 |
| 155 | synaptic transmission, glutamatergic (GO:0035249) | 2.73058498 |
| 156 | proline transport (GO:0015824) | 2.72962903 |
| 157 | retinal cone cell development (GO:0046549) | 2.71403891 |
| 158 | neuronal action potential (GO:0019228) | 2.70456720 |
| 159 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.70315375 |
| 160 | omega-hydroxylase P450 pathway (GO:0097267) | 2.67916079 |
| 161 | presynaptic membrane assembly (GO:0097105) | 2.67252718 |
| 162 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.66064758 |
| 163 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.65299766 |
| 164 | postsynaptic membrane organization (GO:0001941) | 2.64975983 |
| 165 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.63720573 |
| 166 | transmission of nerve impulse (GO:0019226) | 2.63692395 |
| 167 | fucose catabolic process (GO:0019317) | 2.63646255 |
| 168 | L-fucose metabolic process (GO:0042354) | 2.63646255 |
| 169 | L-fucose catabolic process (GO:0042355) | 2.63646255 |
| 170 | glutamate receptor signaling pathway (GO:0007215) | 2.61851771 |
| 171 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.61120850 |
| 172 | tachykinin receptor signaling pathway (GO:0007217) | 2.59527990 |
| 173 | L-methionine salvage (GO:0071267) | 2.58141180 |
| 174 | L-methionine biosynthetic process (GO:0071265) | 2.58141180 |
| 175 | amino acid salvage (GO:0043102) | 2.58141180 |
| 176 | membrane depolarization during action potential (GO:0086010) | 2.57768348 |
| 177 | inner ear receptor stereocilium organization (GO:0060122) | 2.56031262 |
| 178 | interkinetic nuclear migration (GO:0022027) | 2.55471731 |
| 179 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.53600248 |
| 180 | regulation of action potential (GO:0098900) | 2.53491958 |
| 181 | sphingoid metabolic process (GO:0046519) | 2.48260056 |
| 182 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.47820609 |
| 183 | negative regulation of sodium ion transport (GO:0010766) | 2.47722049 |
| 184 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.46687189 |
| 185 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.45641148 |
| 186 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.45641148 |
| 187 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.45641148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.62487032 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.70659763 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.82522562 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.58614296 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.30646076 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.24596729 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.96580318 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.49635092 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.25197557 |
| 10 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.21291824 |
| 11 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.76123944 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.75087803 |
| 13 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.68412624 |
| 14 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.60181101 |
| 15 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.57533533 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.42282697 |
| 17 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.34433869 |
| 18 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.25987613 |
| 19 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.16471364 |
| 20 | P300_19829295_ChIP-Seq_ESCs_Human | 2.09214174 |
| 21 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.03750321 |
| 22 | STAT3_23295773_ChIP-Seq_U87_Human | 1.99561120 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.97523737 |
| 24 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.96962086 |
| 25 | FUS_26573619_Chip-Seq_HEK293_Human | 1.94779297 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91202979 |
| 27 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.84419641 |
| 28 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.84122049 |
| 29 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.82892032 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.73851522 |
| 31 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.72938505 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.69645704 |
| 33 | TCF4_23295773_ChIP-Seq_U87_Human | 1.69525596 |
| 34 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.66774476 |
| 35 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.66488385 |
| 36 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.66451959 |
| 37 | AR_25329375_ChIP-Seq_VCAP_Human | 1.62773163 |
| 38 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.60455324 |
| 39 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.59900828 |
| 40 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.59592231 |
| 41 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.55243126 |
| 42 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.55075871 |
| 43 | TP53_16413492_ChIP-PET_HCT116_Human | 1.54870638 |
| 44 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52408753 |
| 45 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51861693 |
| 46 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51861693 |
| 47 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.47720400 |
| 48 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.46536791 |
| 49 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.43146551 |
| 50 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.40891190 |
| 51 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40395674 |
| 52 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.40395674 |
| 53 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.36202958 |
| 54 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.35594741 |
| 55 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.35353723 |
| 56 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.34819739 |
| 57 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34666300 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.34405854 |
| 59 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.32190263 |
| 60 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.31885459 |
| 61 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.30455655 |
| 62 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.30320735 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26863942 |
| 64 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.26490547 |
| 65 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.25630109 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.24925157 |
| 67 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24632507 |
| 68 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.24331557 |
| 69 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23913684 |
| 70 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.23093960 |
| 71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.22160023 |
| 72 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.21786931 |
| 73 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.20547539 |
| 74 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19396605 |
| 75 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18980738 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18709076 |
| 77 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.17629578 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.14804030 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.14804030 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.14509837 |
| 81 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14219780 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.13845102 |
| 83 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.13342787 |
| 84 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13313901 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.12304932 |
| 86 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.12270145 |
| 87 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11789599 |
| 88 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.11221983 |
| 89 | KDM2B_26808549_Chip-Seq_REH_Human | 1.10593402 |
| 90 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08460901 |
| 91 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08186673 |
| 92 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.07545406 |
| 93 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06790863 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.06508729 |
| 95 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.06325800 |
| 96 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.06240630 |
| 97 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.05924932 |
| 98 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.05508755 |
| 99 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.05241018 |
| 100 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04967832 |
| 101 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03616660 |
| 102 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.03539132 |
| 103 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.03175106 |
| 104 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.02742646 |
| 105 | * AR_19668381_ChIP-Seq_PC3_Human | 1.02509901 |
| 106 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.01729526 |
| 107 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.00702141 |
| 108 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.00445850 |
| 109 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96487456 |
| 110 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96344337 |
| 111 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.93837405 |
| 112 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.93641214 |
| 113 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.91273903 |
| 114 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88931965 |
| 115 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.88870265 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86367633 |
| 117 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85495343 |
| 118 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.84772375 |
| 119 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82679419 |
| 120 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.82177346 |
| 121 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81809406 |
| 122 | CBP_21632823_ChIP-Seq_H3396_Human | 0.81190208 |
| 123 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.80734566 |
| 124 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.78860494 |
| 125 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78685541 |
| 126 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.77894872 |
| 127 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.75342680 |
| 128 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.74873605 |
| 129 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72651430 |
| 130 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.72076293 |
| 131 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71678770 |
| 132 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.71651465 |
| 133 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.69695827 |
| 134 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.69067054 |
| 135 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.68885247 |
| 136 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.68792566 |
| 137 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.68390288 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.67868287 |
| 139 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.67817182 |
| 140 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.66781188 |
| 141 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.66635579 |
| 142 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.66336665 |
| 143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.65064316 |
| 144 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.64559576 |
| 145 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63677943 |
| 146 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.63042411 |
| 147 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.62615653 |
| 148 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.60905483 |
| 149 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.60761415 |
| 150 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.60734605 |
| 151 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.60068664 |
| 152 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.58472364 |
| 153 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.58084460 |
| 154 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.57890707 |
| 155 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.57781428 |
| 156 | VDR_22108803_ChIP-Seq_LS180_Human | 0.57685359 |
| 157 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.57598376 |
| 158 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.57323975 |
| 159 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.57062745 |
| 160 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.56855897 |
| 161 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.56813117 |
| 162 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.55981492 |
| 163 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.55793414 |
| 164 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.54862076 |
| 165 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.54606815 |
| 166 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.54556097 |
| 167 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.54398630 |
| 168 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.54352490 |
| 169 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.54157424 |
| 170 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.54006698 |
| 171 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.54006698 |
| 172 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.53794004 |
| 173 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.53248772 |
| 174 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.53137367 |
| 175 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52910713 |
| 176 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.52638619 |
| 177 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.52249412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.59620270 |
| 2 | MP0005360_urolithiasis | 6.71648863 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.76162265 |
| 4 | MP0005365_abnormal_bile_salt | 5.25996001 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 4.79503428 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.77866934 |
| 7 | MP0000569_abnormal_digit_pigmentation | 4.73466589 |
| 8 | MP0003252_abnormal_bile_duct | 3.42103703 |
| 9 | MP0009046_muscle_twitch | 3.12153078 |
| 10 | MP0009840_abnormal_foam_cell | 3.02016089 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.86777616 |
| 12 | MP0005083_abnormal_biliary_tract | 2.82683042 |
| 13 | MP0003195_calcinosis | 2.73851363 |
| 14 | MP0001968_abnormal_touch/_nociception | 2.69382381 |
| 15 | MP0002736_abnormal_nociception_after | 2.67534948 |
| 16 | MP0001501_abnormal_sleep_pattern | 2.61354707 |
| 17 | MP0005332_abnormal_amino_acid | 2.56695667 |
| 18 | MP0009745_abnormal_behavioral_response | 2.53474290 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.46967266 |
| 20 | MP0000920_abnormal_myelination | 2.31437830 |
| 21 | MP0001984_abnormal_olfaction | 2.19669653 |
| 22 | MP0008057_abnormal_DNA_replication | 2.15257623 |
| 23 | MP0002064_seizures | 2.07504196 |
| 24 | MP0002118_abnormal_lipid_homeostasis | 2.01676892 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.98382008 |
| 26 | MP0005451_abnormal_body_composition | 1.96548229 |
| 27 | MP0002272_abnormal_nervous_system | 1.93112227 |
| 28 | MP0003329_amyloid_beta_deposits | 1.92478937 |
| 29 | MP0003635_abnormal_synaptic_transmissio | 1.87470675 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.83400550 |
| 31 | MP0001486_abnormal_startle_reflex | 1.82678085 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 1.80422861 |
| 33 | MP0004019_abnormal_vitamin_homeostasis | 1.78344900 |
| 34 | MP0006276_abnormal_autonomic_nervous | 1.77702580 |
| 35 | MP0003646_muscle_fatigue | 1.71379638 |
| 36 | MP0004381_abnormal_hair_follicle | 1.70909784 |
| 37 | MP0005253_abnormal_eye_physiology | 1.65611321 |
| 38 | MP0008877_abnormal_DNA_methylation | 1.65214271 |
| 39 | MP0003690_abnormal_glial_cell | 1.64227591 |
| 40 | MP0000609_abnormal_liver_physiology | 1.63655589 |
| 41 | MP0000604_amyloidosis | 1.61682790 |
| 42 | MP0003880_abnormal_central_pattern | 1.61107066 |
| 43 | MP0003011_delayed_dark_adaptation | 1.57273275 |
| 44 | MP0002063_abnormal_learning/memory/cond | 1.57221904 |
| 45 | MP0003868_abnormal_feces_composition | 1.56706605 |
| 46 | MP0004859_abnormal_synaptic_plasticity | 1.56324809 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.55636699 |
| 48 | MP0004924_abnormal_behavior | 1.55272233 |
| 49 | MP0005386_behavior/neurological_phenoty | 1.55272233 |
| 50 | MP0005670_abnormal_white_adipose | 1.50846909 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.50167375 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.48581043 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.46800755 |
| 54 | MP0001970_abnormal_pain_threshold | 1.43137915 |
| 55 | MP0002102_abnormal_ear_morphology | 1.42203331 |
| 56 | MP0003787_abnormal_imprinting | 1.41466943 |
| 57 | MP0008872_abnormal_physiological_respon | 1.40545832 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.39188277 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.38045997 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.36643996 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.33037099 |
| 62 | MP0002733_abnormal_thermal_nociception | 1.32692107 |
| 63 | MP0000778_abnormal_nervous_system | 1.31844470 |
| 64 | MP0002796_impaired_skin_barrier | 1.30924207 |
| 65 | MP0002638_abnormal_pupillary_reflex | 1.29995957 |
| 66 | MP0005408_hypopigmentation | 1.29640454 |
| 67 | MP0002734_abnormal_mechanical_nocicepti | 1.29103603 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.26653263 |
| 69 | MP0001485_abnormal_pinna_reflex | 1.25104373 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 1.23122159 |
| 71 | MP0001764_abnormal_homeostasis | 1.22898358 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.20099884 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.19786735 |
| 74 | MP0002837_dystrophic_cardiac_calcinosis | 1.19361533 |
| 75 | MP0005647_abnormal_sex_gland | 1.18262534 |
| 76 | MP0003186_abnormal_redox_activity | 1.16115365 |
| 77 | MP0009697_abnormal_copulation | 1.13312506 |
| 78 | MP0005171_absent_coat_pigmentation | 1.13153795 |
| 79 | MP0002928_abnormal_bile_duct | 1.11900124 |
| 80 | MP0003950_abnormal_plasma_membrane | 1.09224304 |
| 81 | MP0003045_fibrosis | 1.08942682 |
| 82 | MP0000371_diluted_coat_color | 1.08479460 |
| 83 | MP0003890_abnormal_embryonic-extraembry | 1.07836120 |
| 84 | MP0005310_abnormal_salivary_gland | 1.07618478 |
| 85 | MP0000579_abnormal_nail_morphology | 1.06677033 |
| 86 | MP0003633_abnormal_nervous_system | 1.06298862 |
| 87 | MP0009643_abnormal_urine_homeostasis | 1.05440612 |
| 88 | MP0010678_abnormal_skin_adnexa | 1.03856522 |
| 89 | MP0002184_abnormal_innervation | 1.02377990 |
| 90 | MP0002254_reproductive_system_inflammat | 1.01828052 |
| 91 | MP0000631_abnormal_neuroendocrine_gland | 1.01087693 |
| 92 | MP0002882_abnormal_neuron_morphology | 0.99360770 |
| 93 | MP0001440_abnormal_grooming_behavior | 0.95918199 |
| 94 | MP0002909_abnormal_adrenal_gland | 0.95793886 |
| 95 | MP0004885_abnormal_endolymph | 0.94644712 |
| 96 | MP0005187_abnormal_penis_morphology | 0.94441611 |
| 97 | MP0002938_white_spotting | 0.93215705 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.93036338 |
| 99 | MP0001661_extended_life_span | 0.92316666 |
| 100 | MP0005636_abnormal_mineral_homeostasis | 0.92106908 |
| 101 | MP0002095_abnormal_skin_pigmentation | 0.90509648 |
| 102 | MP0000015_abnormal_ear_pigmentation | 0.89103340 |
| 103 | MP0000647_abnormal_sebaceous_gland | 0.88222490 |
| 104 | MP0004130_abnormal_muscle_cell | 0.87895471 |
| 105 | MP0000955_abnormal_spinal_cord | 0.87232826 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.86928133 |
| 107 | MP0003632_abnormal_nervous_system | 0.85657584 |
| 108 | MP0005423_abnormal_somatic_nervous | 0.85386647 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.84409049 |
| 110 | MP0000383_abnormal_hair_follicle | 0.84008327 |
| 111 | MP0003137_abnormal_impulse_conducting | 0.82627016 |
| 112 | MP0005195_abnormal_posterior_eye | 0.81423135 |
| 113 | MP0000639_abnormal_adrenal_gland | 0.81180175 |
| 114 | MP0002234_abnormal_pharynx_morphology | 0.80926151 |
| 115 | MP0004147_increased_porphyrin_level | 0.80075885 |
| 116 | MP0000538_abnormal_urinary_bladder | 0.80036532 |
| 117 | MP0002752_abnormal_somatic_nervous | 0.79737645 |
| 118 | MP0002168_other_aberrant_phenotype | 0.79004045 |
| 119 | MP0002090_abnormal_vision | 0.78301081 |
| 120 | MP0004142_abnormal_muscle_tone | 0.78004333 |
| 121 | MP0000598_abnormal_liver_morphology | 0.77845083 |
| 122 | MP0009763_increased_sensitivity_to | 0.77399698 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.75017525 |
| 124 | MP0000467_abnormal_esophagus_morphology | 0.73395147 |
| 125 | MP0000462_abnormal_digestive_system | 0.73233421 |
| 126 | MP0004043_abnormal_pH_regulation | 0.68405943 |
| 127 | MP0004742_abnormal_vestibular_system | 0.66700201 |
| 128 | MP0009379_abnormal_foot_pigmentation | 0.66244982 |
| 129 | MP0003634_abnormal_glial_cell | 0.65557415 |
| 130 | MP0005376_homeostasis/metabolism_phenot | 0.64926184 |
| 131 | MP0001529_abnormal_vocalization | 0.64798894 |
| 132 | MP0002876_abnormal_thyroid_physiology | 0.64432738 |
| 133 | MP0003453_abnormal_keratinocyte_physiol | 0.62014795 |
| 134 | MP0003718_maternal_effect | 0.62010046 |
| 135 | MP0002229_neurodegeneration | 0.61933346 |
| 136 | MP0001905_abnormal_dopamine_level | 0.61867195 |
| 137 | MP0009642_abnormal_blood_homeostasis | 0.61346707 |
| 138 | MP0010368_abnormal_lymphatic_system | 0.60734218 |
| 139 | MP0000566_synostosis | 0.60373318 |
| 140 | MP0004270_analgesia | 0.60369694 |
| 141 | MP0009764_decreased_sensitivity_to | 0.59011663 |
| 142 | MP0006036_abnormal_mitochondrial_physio | 0.58758050 |
| 143 | MP0005501_abnormal_skin_physiology | 0.56869675 |
| 144 | MP0009384_cardiac_valve_regurgitation | 0.55985841 |
| 145 | MP0005084_abnormal_gallbladder_morpholo | 0.53689140 |
| 146 | MP0003631_nervous_system_phenotype | 0.52664580 |
| 147 | MP0009053_abnormal_anal_canal | 0.52044131 |
| 148 | MP0005410_abnormal_fertilization | 0.51564443 |
| 149 | MP0008469_abnormal_protein_level | 0.51159793 |
| 150 | MP0005551_abnormal_eye_electrophysiolog | 0.50063399 |
| 151 | MP0002295_abnormal_pulmonary_circulatio | 0.49473855 |
| 152 | MP0005220_abnormal_exocrine_pancreas | 0.49310262 |
| 153 | MP0001177_atelectasis | 0.49031001 |
| 154 | MP0008874_decreased_physiological_sensi | 0.48781842 |
| 155 | MP0001346_abnormal_lacrimal_gland | 0.48504653 |
| 156 | MP0000427_abnormal_hair_cycle | 0.48427750 |
| 157 | MP0003136_yellow_coat_color | 0.48212387 |
| 158 | MP0000377_abnormal_hair_follicle | 0.47749266 |
| 159 | MP0006082_CNS_inflammation | 0.45293916 |
| 160 | MP0002098_abnormal_vibrissa_morphology | 0.44772076 |
| 161 | MP0005058_abnormal_lysosome_morphology | 0.44236964 |
| 162 | MP0001340_abnormal_eyelid_morphology | 0.43732913 |
| 163 | MP0002971_abnormal_brown_adipose | 0.43690139 |
| 164 | MP0002060_abnormal_skin_morphology | 0.43620103 |
| 165 | MP0001243_abnormal_dermal_layer | 0.42362030 |
| 166 | MP0005266_abnormal_metabolism | 0.41643186 |
| 167 | MP0003638_abnormal_response/metabolism_ | 0.41594527 |
| 168 | MP0005395_other_phenotype | 0.40954243 |
| 169 | MP0005535_abnormal_body_temperature | 0.40013376 |
| 170 | MP0008873_increased_physiological_sensi | 0.39942578 |
| 171 | MP0000230_abnormal_systemic_arterial | 0.39216502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.37720272 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.21188518 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.47187224 |
| 4 | Xanthomatosis (HP:0000991) | 5.69694597 |
| 5 | Genetic anticipation (HP:0003743) | 5.67310910 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.64727423 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 5.54721441 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 5.42314332 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.15154621 |
| 10 | Hyperventilation (HP:0002883) | 5.11822288 |
| 11 | Complement deficiency (HP:0004431) | 5.11277526 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 4.71799181 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 4.40990730 |
| 14 | Pancreatic cysts (HP:0001737) | 4.16615865 |
| 15 | Fat malabsorption (HP:0002630) | 4.10771499 |
| 16 | Abnormality of methionine metabolism (HP:0010901) | 4.09315042 |
| 17 | Epidermoid cyst (HP:0200040) | 4.08476487 |
| 18 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.86580108 |
| 19 | Hypolipoproteinemia (HP:0010981) | 3.79687911 |
| 20 | Hyperammonemia (HP:0001987) | 3.74354910 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.67282301 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.64736421 |
| 23 | Hyperglycinemia (HP:0002154) | 3.64472672 |
| 24 | Joint hemorrhage (HP:0005261) | 3.63868044 |
| 25 | True hermaphroditism (HP:0010459) | 3.62261151 |
| 26 | Abnormality of complement system (HP:0005339) | 3.58690756 |
| 27 | Pancreatic fibrosis (HP:0100732) | 3.58634551 |
| 28 | Neurofibrillary tangles (HP:0002185) | 3.56259934 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.52806408 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.50640947 |
| 31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.50640947 |
| 32 | Abnormality of the common coagulation pathway (HP:0010990) | 3.49781733 |
| 33 | Ketosis (HP:0001946) | 3.46578631 |
| 34 | Steatorrhea (HP:0002570) | 3.41316480 |
| 35 | Febrile seizures (HP:0002373) | 3.31606179 |
| 36 | Focal seizures (HP:0007359) | 3.31259554 |
| 37 | Fair hair (HP:0002286) | 3.30871956 |
| 38 | Protruding tongue (HP:0010808) | 3.29978397 |
| 39 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.29417130 |
| 40 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.29417130 |
| 41 | Congenital sensorineural hearing impairment (HP:0008527) | 3.20721183 |
| 42 | Attenuation of retinal blood vessels (HP:0007843) | 3.17072861 |
| 43 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.12354953 |
| 44 | Parakeratosis (HP:0001036) | 3.12261905 |
| 45 | Dialeptic seizures (HP:0011146) | 3.11305266 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 3.08472285 |
| 47 | Focal motor seizures (HP:0011153) | 3.06404530 |
| 48 | Dysmetric saccades (HP:0000641) | 3.04169046 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.03633093 |
| 50 | Congenital stationary night blindness (HP:0007642) | 3.03230525 |
| 51 | Absence seizures (HP:0002121) | 2.97827412 |
| 52 | Absent speech (HP:0001344) | 2.97237815 |
| 53 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.96855106 |
| 54 | Clumsiness (HP:0002312) | 2.94665924 |
| 55 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.92983296 |
| 56 | Abnormality of midbrain morphology (HP:0002418) | 2.90073265 |
| 57 | Molar tooth sign on MRI (HP:0002419) | 2.90073265 |
| 58 | Hyperglycinuria (HP:0003108) | 2.88362026 |
| 59 | Delayed CNS myelination (HP:0002188) | 2.86391717 |
| 60 | Abnormality of the intrinsic pathway (HP:0010989) | 2.84811757 |
| 61 | Chronic hepatic failure (HP:0100626) | 2.84086181 |
| 62 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.83455550 |
| 63 | Hypercholesterolemia (HP:0003124) | 2.82593054 |
| 64 | Hypoglycemic coma (HP:0001325) | 2.79470578 |
| 65 | Broad-based gait (HP:0002136) | 2.77142584 |
| 66 | Abnormality of the renal cortex (HP:0011035) | 2.76538242 |
| 67 | Inability to walk (HP:0002540) | 2.74109000 |
| 68 | Abnormality of the corticospinal tract (HP:0002492) | 2.73726911 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.72993079 |
| 70 | Cystic liver disease (HP:0006706) | 2.70471614 |
| 71 | Cerebral inclusion bodies (HP:0100314) | 2.69912927 |
| 72 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.69425168 |
| 73 | Nephronophthisis (HP:0000090) | 2.68729679 |
| 74 | Abnormality of alanine metabolism (HP:0010916) | 2.67929050 |
| 75 | Hyperalaninemia (HP:0003348) | 2.67929050 |
| 76 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.67929050 |
| 77 | Generalized hypopigmentation of hair (HP:0011358) | 2.67288795 |
| 78 | Cholecystitis (HP:0001082) | 2.59902647 |
| 79 | Abnormal gallbladder physiology (HP:0012438) | 2.59902647 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.55452169 |
| 81 | Abnormality of the renal medulla (HP:0100957) | 2.55297996 |
| 82 | Vascular calcification (HP:0004934) | 2.55261723 |
| 83 | Abolished electroretinogram (ERG) (HP:0000550) | 2.54813660 |
| 84 | Medial flaring of the eyebrow (HP:0010747) | 2.54158345 |
| 85 | Abnormality of glycolysis (HP:0004366) | 2.49598978 |
| 86 | Increased serum pyruvate (HP:0003542) | 2.49598978 |
| 87 | Hypochromic microcytic anemia (HP:0004840) | 2.49184919 |
| 88 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.48257937 |
| 89 | Spastic paraparesis (HP:0002313) | 2.47148405 |
| 90 | Progressive inability to walk (HP:0002505) | 2.46324527 |
| 91 | Amyloidosis (HP:0011034) | 2.45596348 |
| 92 | Abnormal gallbladder morphology (HP:0012437) | 2.42870372 |
| 93 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.39107936 |
| 94 | Gait imbalance (HP:0002141) | 2.39063732 |
| 95 | Hypophosphatemic rickets (HP:0004912) | 2.36818057 |
| 96 | Spontaneous abortion (HP:0005268) | 2.35016182 |
| 97 | Malnutrition (HP:0004395) | 2.34158696 |
| 98 | Action tremor (HP:0002345) | 2.34075933 |
| 99 | Rickets (HP:0002748) | 2.32335530 |
| 100 | Drooling (HP:0002307) | 2.31925318 |
| 101 | Cerebral edema (HP:0002181) | 2.31003400 |
| 102 | Metabolic acidosis (HP:0001942) | 2.30090994 |
| 103 | Irritability (HP:0000737) | 2.28031831 |
| 104 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27258082 |
| 105 | Lethargy (HP:0001254) | 2.27049383 |
| 106 | Hepatocellular carcinoma (HP:0001402) | 2.26846154 |
| 107 | Systemic lupus erythematosus (HP:0002725) | 2.26426806 |
| 108 | Sensory axonal neuropathy (HP:0003390) | 2.26015490 |
| 109 | Furrowed tongue (HP:0000221) | 2.25315247 |
| 110 | Hemiparesis (HP:0001269) | 2.24428340 |
| 111 | Widely spaced teeth (HP:0000687) | 2.24246444 |
| 112 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.22257751 |
| 113 | Dicarboxylic aciduria (HP:0003215) | 2.22257751 |
| 114 | Cardiovascular calcification (HP:0011915) | 2.21944784 |
| 115 | Large for gestational age (HP:0001520) | 2.20035360 |
| 116 | Cholelithiasis (HP:0001081) | 2.19953660 |
| 117 | Opisthotonus (HP:0002179) | 2.19912375 |
| 118 | Congenital primary aphakia (HP:0007707) | 2.19424320 |
| 119 | Ketoacidosis (HP:0001993) | 2.19421098 |
| 120 | Acanthocytosis (HP:0001927) | 2.17256156 |
| 121 | Keratoconus (HP:0000563) | 2.15178788 |
| 122 | Increased corneal curvature (HP:0100692) | 2.15178788 |
| 123 | Brushfield spots (HP:0001088) | 2.15140031 |
| 124 | Spastic diplegia (HP:0001264) | 2.14706608 |
| 125 | Cerebellar dysplasia (HP:0007033) | 2.13614756 |
| 126 | Skin nodule (HP:0200036) | 2.12144641 |
| 127 | Lissencephaly (HP:0001339) | 2.12060637 |
| 128 | Sclerocornea (HP:0000647) | 2.11579431 |
| 129 | Tubular atrophy (HP:0000092) | 2.10614324 |
| 130 | Abnormality of nucleobase metabolism (HP:0010932) | 2.10237078 |
| 131 | Impaired smooth pursuit (HP:0007772) | 2.10207439 |
| 132 | Decreased circulating renin level (HP:0003351) | 2.10158524 |
| 133 | Hypoplastic labia majora (HP:0000059) | 2.09395654 |
| 134 | Cerebral hemorrhage (HP:0001342) | 2.08685841 |
| 135 | Atonic seizures (HP:0010819) | 2.08508476 |
| 136 | Abnormality of vitamin metabolism (HP:0100508) | 2.07291333 |
| 137 | Preaxial foot polydactyly (HP:0001841) | 2.06716329 |
| 138 | Abnormality of the ischium (HP:0003174) | 2.05795385 |
| 139 | Myocardial infarction (HP:0001658) | 2.04185007 |
| 140 | Type II lissencephaly (HP:0007260) | 2.04041221 |
| 141 | Excessive salivation (HP:0003781) | 2.03979508 |
| 142 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.03924635 |
| 143 | Postural instability (HP:0002172) | 2.03662938 |
| 144 | Genital tract atresia (HP:0001827) | 2.03112909 |
| 145 | Pendular nystagmus (HP:0012043) | 2.02804721 |
| 146 | Spastic paraplegia (HP:0001258) | 2.00650416 |
| 147 | Epileptic encephalopathy (HP:0200134) | 1.99642219 |
| 148 | Abnormality of the gallbladder (HP:0005264) | 1.99174367 |
| 149 | Nephrogenic diabetes insipidus (HP:0009806) | 1.97426213 |
| 150 | Axonal loss (HP:0003447) | 1.96985089 |
| 151 | Abnormality of macular pigmentation (HP:0008002) | 1.96529906 |
| 152 | Central scotoma (HP:0000603) | 1.96485547 |
| 153 | Abnormality of purine metabolism (HP:0004352) | 1.95801649 |
| 154 | Hypoplastic ischia (HP:0003175) | 1.94400160 |
| 155 | Chorioretinal atrophy (HP:0000533) | 1.94062757 |
| 156 | Vaginal atresia (HP:0000148) | 1.93770223 |
| 157 | Paraplegia (HP:0010550) | 1.92312305 |
| 158 | Blue irides (HP:0000635) | 1.91792128 |
| 159 | Abnormality of the labia majora (HP:0012881) | 1.91363236 |
| 160 | Intention tremor (HP:0002080) | 1.91224866 |
| 161 | Methylmalonic acidemia (HP:0002912) | 1.90504681 |
| 162 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.89547371 |
| 163 | Alkalosis (HP:0001948) | 1.88421225 |
| 164 | Epileptiform EEG discharges (HP:0011182) | 1.86624179 |
| 165 | Congenital hepatic fibrosis (HP:0002612) | 1.86265092 |
| 166 | Vomiting (HP:0002013) | 1.86262898 |
| 167 | Gout (HP:0001997) | 1.86123438 |
| 168 | Renal cortical cysts (HP:0000803) | 1.85963106 |
| 169 | Intestinal atresia (HP:0011100) | 1.85805017 |
| 170 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.84968598 |
| 171 | Abnormal drinking behavior (HP:0030082) | 1.83556141 |
| 172 | Polydipsia (HP:0001959) | 1.83556141 |
| 173 | Hypoglycemic seizures (HP:0002173) | 1.83232459 |
| 174 | Paraparesis (HP:0002385) | 1.82703425 |
| 175 | Patellar aplasia (HP:0006443) | 1.82622904 |
| 176 | Hemorrhage of the eye (HP:0011885) | 1.82175507 |
| 177 | Pancreatitis (HP:0001733) | 1.81781716 |
| 178 | Small hand (HP:0200055) | 1.81731845 |
| 179 | Spastic gait (HP:0002064) | 1.81552109 |
| 180 | EEG with generalized epileptiform discharges (HP:0011198) | 1.81057803 |
| 181 | Highly arched eyebrow (HP:0002553) | 1.80843375 |
| 182 | Poor coordination (HP:0002370) | 1.80449796 |
| 183 | Hypsarrhythmia (HP:0002521) | 1.80012833 |
| 184 | Enlarged kidneys (HP:0000105) | 1.80007577 |
| 185 | Spastic tetraparesis (HP:0001285) | 1.79971133 |
| 186 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.79936952 |
| 187 | Short foot (HP:0001773) | 1.79811984 |
| 188 | Glomerulonephritis (HP:0000099) | 1.79721784 |
| 189 | Confusion (HP:0001289) | 1.79553270 |
| 190 | Decreased central vision (HP:0007663) | 1.79052936 |
| 191 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.78488591 |
| 192 | Neonatal onset (HP:0003623) | 1.77729428 |
| 193 | Intellectual disability, progressive (HP:0006887) | 1.77249097 |
| 194 | Bile duct proliferation (HP:0001408) | 1.75348876 |
| 195 | Abnormal biliary tract physiology (HP:0012439) | 1.75348876 |
| 196 | Male pseudohermaphroditism (HP:0000037) | 1.74938772 |
| 197 | Sensorimotor neuropathy (HP:0007141) | 1.73631437 |
| 198 | Cupped ear (HP:0000378) | 1.73248765 |
| 199 | Anencephaly (HP:0002323) | 1.72662432 |
| 200 | Preaxial hand polydactyly (HP:0001177) | 1.72080339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.30560396 |
| 2 | OXSR1 | 3.98898588 |
| 3 | BCKDK | 3.98382445 |
| 4 | EPHB1 | 3.44887293 |
| 5 | ACVR1B | 3.05772476 |
| 6 | MET | 3.01138578 |
| 7 | BMPR1B | 2.75209208 |
| 8 | PKN1 | 2.74217961 |
| 9 | PBK | 2.73455529 |
| 10 | FGFR2 | 2.62552650 |
| 11 | ERBB4 | 2.52395538 |
| 12 | BCR | 2.52220177 |
| 13 | WNK3 | 2.26304751 |
| 14 | ADRBK2 | 2.17012138 |
| 15 | WNK4 | 2.07364581 |
| 16 | CSNK1G3 | 2.03895476 |
| 17 | FGFR4 | 2.00757598 |
| 18 | FRK | 10.0956135 |
| 19 | MAPK13 | 1.97522874 |
| 20 | LIMK1 | 1.96352553 |
| 21 | SIK1 | 1.94717693 |
| 22 | MAPKAPK5 | 1.93048256 |
| 23 | CSNK1A1L | 1.92583419 |
| 24 | NTRK3 | 1.88643125 |
| 25 | TESK2 | 1.82871028 |
| 26 | MAP3K4 | 1.81811983 |
| 27 | STK38L | 1.77810051 |
| 28 | CSNK1G1 | 1.75238018 |
| 29 | CDK19 | 1.74416259 |
| 30 | MST1R | 1.68343975 |
| 31 | ZAK | 1.58054763 |
| 32 | ERN1 | 1.51763042 |
| 33 | CSNK1G2 | 1.51017983 |
| 34 | MAP4K2 | 1.50501616 |
| 35 | INSRR | 1.46170168 |
| 36 | CAMK2G | 1.38133123 |
| 37 | MAPK15 | 1.34634149 |
| 38 | CAMK2B | 1.33674888 |
| 39 | MKNK2 | 1.33575913 |
| 40 | MST4 | 1.33099946 |
| 41 | PRPF4B | 1.26398634 |
| 42 | NTRK1 | 1.25422680 |
| 43 | PIK3CG | 1.20469686 |
| 44 | WNK1 | 1.20208164 |
| 45 | FER | 1.20176569 |
| 46 | ICK | 1.19136757 |
| 47 | ABL2 | 1.12294026 |
| 48 | TAOK3 | 1.09631743 |
| 49 | CAMKK2 | 1.08307818 |
| 50 | ADRBK1 | 1.08240846 |
| 51 | DYRK2 | 1.05712307 |
| 52 | SGK494 | 1.03258113 |
| 53 | SGK223 | 1.03258113 |
| 54 | AKT3 | 1.02360944 |
| 55 | MAP2K7 | 1.01107896 |
| 56 | PAK3 | 1.00086878 |
| 57 | TGFBR1 | 0.99795288 |
| 58 | PRKCG | 0.99017184 |
| 59 | NUAK1 | 0.96908062 |
| 60 | ROCK2 | 0.96873251 |
| 61 | CAMK2D | 0.96670766 |
| 62 | EPHA4 | 0.95377601 |
| 63 | TNIK | 0.94934202 |
| 64 | PRKCQ | 0.86843419 |
| 65 | UHMK1 | 0.86637466 |
| 66 | MARK1 | 0.85927739 |
| 67 | STK3 | 0.85629874 |
| 68 | FGR | 0.85514694 |
| 69 | TRIM28 | 0.84335228 |
| 70 | SGK2 | 0.83112787 |
| 71 | STK38 | 0.81700411 |
| 72 | GSK3A | 0.80787223 |
| 73 | MAP2K4 | 0.80103176 |
| 74 | PLK2 | 0.78785671 |
| 75 | PDPK1 | 0.78175543 |
| 76 | MAP2K2 | 0.77737616 |
| 77 | NTRK2 | 0.73716397 |
| 78 | SIK2 | 0.73299407 |
| 79 | CAMK1G | 0.69826231 |
| 80 | BRD4 | 0.69116159 |
| 81 | ERBB2 | 0.68945608 |
| 82 | PRKCZ | 0.68770512 |
| 83 | CAMK2A | 0.67989037 |
| 84 | PRKD1 | 0.66677629 |
| 85 | IRAK1 | 0.66578725 |
| 86 | PNCK | 0.66191837 |
| 87 | PTK2B | 0.65959776 |
| 88 | MAPK4 | 0.65653003 |
| 89 | MAPK11 | 0.65517758 |
| 90 | ERBB3 | 0.64104884 |
| 91 | TRPM7 | 0.63163072 |
| 92 | LATS1 | 0.60888282 |
| 93 | NEK6 | 0.60480633 |
| 94 | BRSK2 | 0.57823397 |
| 95 | MAP3K7 | 0.55037389 |
| 96 | TXK | 0.54479273 |
| 97 | CSNK1D | 0.53422458 |
| 98 | MARK2 | 0.51596685 |
| 99 | MAPK7 | 0.51328476 |
| 100 | MAP3K2 | 0.50468467 |
| 101 | PTK6 | 0.50335467 |
| 102 | PRKAA1 | 0.48881776 |
| 103 | MKNK1 | 0.48824813 |
| 104 | CAMK1D | 0.48083601 |
| 105 | MAP3K13 | 0.46521759 |
| 106 | MAPKAPK3 | 0.46022477 |
| 107 | GRK1 | 0.45600020 |
| 108 | CDK14 | 0.44910871 |
| 109 | PTK2 | 0.44591886 |
| 110 | CLK1 | 0.44501461 |
| 111 | PRKACB | 0.43812160 |
| 112 | GRK7 | 0.43248553 |
| 113 | PRKG1 | 0.43194815 |
| 114 | PRKACG | 0.42381754 |
| 115 | STK11 | 0.41358437 |
| 116 | MAP2K1 | 0.40696359 |
| 117 | PHKG1 | 0.40372282 |
| 118 | PHKG2 | 0.40372282 |
| 119 | JAK2 | 0.39198723 |
| 120 | TYRO3 | 0.38655374 |
| 121 | CHEK2 | 0.38354735 |
| 122 | CDK5 | 0.38237090 |
| 123 | PRKCE | 0.38034904 |
| 124 | PIK3CA | 0.37811559 |
| 125 | CAMK1 | 0.37516740 |
| 126 | MAPK12 | 0.37470627 |
| 127 | PRKAA2 | 0.36984923 |
| 128 | PAK2 | 0.36778813 |
| 129 | SGK1 | 0.35891733 |
| 130 | CDK3 | 0.35877294 |
| 131 | CASK | 0.35838562 |
| 132 | CSNK1E | 0.35686236 |
| 133 | CAMK4 | 0.35382898 |
| 134 | CDK15 | 0.35232466 |
| 135 | FYN | 0.34168467 |
| 136 | DAPK2 | 0.34147406 |
| 137 | DAPK3 | 0.33958063 |
| 138 | PAK6 | 0.32304491 |
| 139 | BMX | 0.32294061 |
| 140 | MELK | 0.32232452 |
| 141 | EPHA3 | 0.31761353 |
| 142 | EGFR | 0.31744014 |
| 143 | KSR2 | 0.31715806 |
| 144 | PRKCH | 0.30824078 |
| 145 | DYRK1B | 0.30705760 |
| 146 | PINK1 | 0.30687327 |
| 147 | CSNK1A1 | 0.29324004 |
| 148 | GRK5 | 0.28967088 |
| 149 | PDK1 | 0.28062251 |
| 150 | PRKACA | 0.27923349 |
| 151 | CDK18 | 0.27678431 |
| 152 | IRAK2 | 0.27289498 |
| 153 | DYRK1A | 0.27232119 |
| 154 | PRKCB | 0.25963510 |
| 155 | PRKCA | 0.25838442 |
| 156 | RPS6KA3 | 0.25767142 |
| 157 | NLK | 0.25720730 |
| 158 | TNK2 | 0.25615700 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.16998284 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.40763157 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.28439381 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.23014066 |
| 5 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.80869204 |
| 6 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.80632423 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.78607390 |
| 8 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.71942805 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.55249383 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.49884227 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48823966 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.41948600 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.38172245 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.37831094 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37265253 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.37174890 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.36981864 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.24373498 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.13364213 |
| 20 | Phototransduction_Homo sapiens_hsa04744 | 2.12365204 |
| 21 | Peroxisome_Homo sapiens_hsa04146 | 2.03089569 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.97207555 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.94770616 |
| 24 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.91284863 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90550797 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90061045 |
| 27 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.87132841 |
| 28 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.86153625 |
| 29 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.85059454 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.83824157 |
| 31 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.82143773 |
| 32 | GABAergic synapse_Homo sapiens_hsa04727 | 1.81117771 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.78461876 |
| 34 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.78249903 |
| 35 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77591067 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.77590636 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.63921337 |
| 38 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.63239159 |
| 39 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.62321878 |
| 40 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62250394 |
| 41 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.61817424 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.61039228 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57931382 |
| 44 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.50187540 |
| 45 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.46428337 |
| 46 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45956223 |
| 47 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.40711652 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.39072074 |
| 49 | Salivary secretion_Homo sapiens_hsa04970 | 1.36053235 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34360942 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 1.34089972 |
| 52 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33946016 |
| 53 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33560320 |
| 54 | Bile secretion_Homo sapiens_hsa04976 | 1.31902801 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31072765 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.29597106 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.21102946 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.16902916 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15278002 |
| 60 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15145758 |
| 61 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12223862 |
| 62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.12196357 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 1.07457071 |
| 64 | ABC transporters_Homo sapiens_hsa02010 | 1.06480627 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.04450156 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.03772024 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.03729467 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01882393 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00215067 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95211804 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92071148 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91410240 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.91009611 |
| 74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90221310 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.90123804 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.88320485 |
| 77 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.84195527 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.82974790 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.81054522 |
| 80 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.79417769 |
| 81 | Homologous recombination_Homo sapiens_hsa03440 | 0.79106039 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.77884050 |
| 83 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77735545 |
| 84 | Cocaine addiction_Homo sapiens_hsa05030 | 0.75535820 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74213082 |
| 86 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.74045560 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73277398 |
| 88 | Circadian rhythm_Homo sapiens_hsa04710 | 0.72703572 |
| 89 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.72243929 |
| 90 | Renin secretion_Homo sapiens_hsa04924 | 0.71469998 |
| 91 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71025033 |
| 92 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69489700 |
| 93 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.68658329 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66014233 |
| 95 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.65244215 |
| 96 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59727304 |
| 97 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58311147 |
| 98 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57639070 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.54427082 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53136732 |
| 101 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53023475 |
| 102 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49586885 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.47877726 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.45713880 |
| 105 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.44299993 |
| 106 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.43917742 |
| 107 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41785144 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.40985286 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39171462 |
| 110 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37995558 |
| 111 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37913299 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32062951 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30879993 |
| 114 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.29165334 |
| 115 | Protein export_Homo sapiens_hsa03060 | 0.29058621 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27884782 |
| 117 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.25636265 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22528718 |
| 119 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.21155747 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.21061986 |
| 121 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.20348374 |
| 122 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.10424095 |
| 123 | Parkinsons disease_Homo sapiens_hsa05012 | 0.07993548 |
| 124 | Alzheimers disease_Homo sapiens_hsa05010 | 0.07085788 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.03326717 |
| 126 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.00655693 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1981832 |
| 128 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.1978420 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | -0.1910271 |
| 130 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1837151 |
| 131 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1815554 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | -0.1669974 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | -0.1566499 |
| 134 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1554588 |
| 135 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1515562 |
| 136 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1482046 |
| 137 | Insulin resistance_Homo sapiens_hsa04931 | -0.1308059 |
| 138 | Lysosome_Homo sapiens_hsa04142 | -0.1307706 |
| 139 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | -0.1182635 |
| 140 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | -0.0982640 |
| 141 | Tight junction_Homo sapiens_hsa04530 | -0.0924096 |
| 142 | Mineral absorption_Homo sapiens_hsa04978 | -0.0164409 |
| 143 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0102527 |

